Skip to main content
Log in

The role of oxidative stress in diseases caused by mineral dusts and fibres: Current status and future of prophylaxis and treatment

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Inhalation of silica and asbestos fibres by humans can lead to fibrosis of the lung and cancer. Different mechanistic approaches, including oxidative stress, are used for prophylactic and therapeutic interventions to attenuate the fibrogenic and carcinogenic effects of these particles. Thus far, most of these therapeutic interventions have been only partly successful. A review of the mechanisms which are thought to be involved in mineral particle-induced toxicity and the relevant therapeutic interventions used to date to counteract these mechanisms, will help formulate better prophylactic and treatment intervention strategies in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A: Relation of particle dimension to carcinogenicity in amphibole asbestos and other fibrous minerals. J Natl Cancer Inst 67: 965–975, 1981

    Google Scholar 

  2. Hochelia MF Jr: Surface chemistry, structure, and reactivity of hazardous mineral dusts. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, pp 275–308

    Google Scholar 

  3. Nash T, Allison AC, Harington JS: Physico-chemical properties of silica in relation to its toxicity. Nature 210: 259–261, 1966

    Google Scholar 

  4. Nolan RP, Langer AM, Harington JS, Oster G, Selikoff IJ: Quartz hemolysis as related to its surface functionalities. Environ Res 26: 503–520, 1981

    Google Scholar 

  5. Fubini B, Bolis V, Cavenago A, Volante M: Physico-chemical properties of crystalline silica dusts and their possible implication in various biological responses. Scan J Work Environ Health 21(suppl 2): 9–14, 1995

    Google Scholar 

  6. Weitzman SA, Graceffa P: Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 228: 373–376, 1984

    Google Scholar 

  7. Eberhardt MK, Romàn-Franco AA, Quiles MR: Asbestos-induced decomposition of hydrogen peroxide. Environ Res 37: 287–292, 1985

    Google Scholar 

  8. Gulumian M, van Wyk JA: Hydroxyl radical production in the presence of fibres by a Fenton-type reaction. Chem-Biol Interact 62: 89–97, 1987

    Google Scholar 

  9. Vallyathan V, Mega J F, Shi X, Dalal NS: Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am J Resp Cell Mol Biol 6: 404–413, 1992

    Google Scholar 

  10. Hatch GE, Gardner DE, Menzel DB: Stimulation of oxidant production in alveolar macrophages by pollutant and latex particles. Environ Res 23: 121–136, 1980

    Google Scholar 

  11. Berg I, Schlüter T, Gercken G: Increase of bovine alveolar macrophage superoxide anion and hydrogen peroxide release by dusts of different origin. J Toxicol Environ Health 39: 341–354, 1993

    Google Scholar 

  12. Ishizaki T, Yano E, Urano N, Evans PH: Crocidolite-induced reactive oxygen metabolites generation from human polymorphonuclear leukocytes. Environ Res 66: 208–216, 1994

    Google Scholar 

  13. Hansen K, Mossman BT: Generation of superoxide (O2 -·) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 47: 1681–1686, 1987

    Google Scholar 

  14. Dubois CM, Bissonnette E, Rola-Pleszczynski M: Asbestos fibres and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Resp Dis 139: 1257–1264, 1989

    Google Scholar 

  15. Heaney PJ, Banfield JA: Structure and chemistry of silica, metal oxides, and phosphates. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, 185–233.

    Google Scholar 

  16. Veblen DR, Wylie AG: Mineralogy of amphiboles and 1:1 layer silicates. In: G.D. Guthrie Jr, B.T. Mossman (eds). Health Effects of Mineral Dusts. Reviews in Mineralogy, Vol. 28. Mineralogy Society of America, Washington, 1993, 61–137

    Google Scholar 

  17. Hearne GR, Kolk B, Pollak H, van Wyk JA, Gulumian M: Bulk and surface modifications in detoxified crocidolite. J Inorg Biochem 50: 145–156, 1993

    Google Scholar 

  18. Brown GM, Donaldson K, Brown DM: Bronchoalveolar leukocyte response in experimental silicosis: Modulation by a soluble aluminum compound. Toxicol Appl Pharmacol 101: 95–105, 1989

    Google Scholar 

  19. Dufresne A, Sébastien P, Michaud D, Perrault G, Bégin R: Influence of aluminum treatments on pulmonary retention of quartz in sheep silicosis. Exp Lung Res 20: 157–168, 1994

    Google Scholar 

  20. Bégin R, Massé S, Dufresne A: Further information on aluminium inhalation in silicosis. Occup Environ Med 52: 778–780, 1995

    Google Scholar 

  21. Schlipköter HW, Brockhaus A: The action of polyvinyl pyridine on experimental silicosis. Dtsch Med Wochenschr 85: 920–923, 1960

    Google Scholar 

  22. Kaw JL, Beck EC, Bruck J: Studies of quartz cytotoxicity on peritoneal macrophages of guinea pigs pretreated with polyvinyl pyridine N-oxide. Environ Res 9: 313–320, 1975

    Google Scholar 

  23. Von Behren LA, Chudhary S, Rabinovich E, Shu MO, Tewari RP: Protective effect of poly-2–vinyl pyridine-N-oxide on susceptibility of silica-treated mice to experimental histoplasmosis. Infect Immun 42: 818–823, 1983

    Google Scholar 

  24. Jinduo Z, Jundge L, Guizhi L: Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis. Zentralbl Bakteriol Hyg I Abt Orig B 178: 259–262, 1983

    Google Scholar 

  25. Davis JMG: The effects of polyvinylpyridine-N-oxide (P204) on the cytopathogenic action of chrysotile asbestos in vivo and in vitro. Br J Exp Pathol 53: 652–658, 1972

    Google Scholar 

  26. Schlipköter HW, Brockhaus A: Die Hemmung der experimentallen Silikose durch subcutane Verabreichung von poly-vinylpyridine-N-oxyd. Klin Wochenschr 39: 1182–1189, 1961

    Google Scholar 

  27. Marchisio MA, Comolli R: Studio metabolico e morfologico deil'attività liticoprotettiva delia poli-2–vinil-piridina-N-ossido su macrofagi peritoneali trattati con silice. Med Lav 55: 401–410, 1964

    Google Scholar 

  28. Mao Y, Lambert ND, Knapton AD, Shi X, Saffiotti U: Protective effects of silanol group binding agents on quartz toxicity to rat lung alveolar cells. Appl Occup Environ Hyg 10: 1132–1137, 1995

    Google Scholar 

  29. Gulumian M, van Wyk A: Free radical scavenging properties of polyvinylpyridine N-oxide: A possible mechanism for its action in pneumoconiosis. 78: 124–128, 1987.

    Google Scholar 

  30. Emerson RJ, Davis GS: Effect of alveolar lining material-coated silica on rat alveolar macrophages. Environ Health Perspect 51: 81–84, 1983

    Google Scholar 

  31. Wallace WE, Vallyathan V, Keane MJ, Robinson V: In vitro biologic toxicity of native and surface modified silica and kaolin. J Toxicol Environ Health 16: 415–424, 1985

    Google Scholar 

  32. Schimmelpfeng J, Drosselmeyer E, Hofheinz V, Seidel A: Influence of surfactant components and exposure geometry on the effects of quartz and asbestos on alveolar macrophages. Environ Health Perspect 97: 225–231, 1992

    Google Scholar 

  33. Jabbour AJ, Holian A, Scheule RK: Lung lining fluid modification of asbestos bioactivity for the alveolar macrophage. Toxicol Appl Pharmacol 110: 283–294, 1991

    Google Scholar 

  34. Antonini JM, Reasor MJ: Effect of short-term exogenous pulmonary surfactant treatment on acute lung damage associated with the intratracheal instillation of silica. J Toxicol Environ Health 43: 85–101, 1994

    Google Scholar 

  35. Antonini JM, McCloud CM, Reasor MJ: Acute silica toxicity: Attenuation by amiodarone-induced pulmonary phospholipidosis. Environ Health Perspect 102: 372–378, 1994

    Google Scholar 

  36. Blake TL, DiMatteo M, Antonini JM, McCloud CM, Reasor MJ: Subchronic pulmonary inflammation and fibrosis induced by silica in rats are attenuated by amiodarone. Exp Lung Res 22: 113–131, 1996

    Google Scholar 

  37. Brown RC, Carthew P, Hoskins JA, Sara E, Simpson CF: Surface modification can affect the carcinogenicity of asbestos. Carcinogenesis 11: 1883–1885, 1990

    Google Scholar 

  38. Vallyathan V, Kang JH, Van Dyke K, Dalal NS, Castranova V: Response of alveolar macrophages to in vitro exposure to freshly fractured versus aged silica dust: The ability of Prosil 28, an organosilane material, to coat silica and reduce its biological reactivity. 33: 303–315, 1991

    Google Scholar 

  39. Wiessner JH, Mandel NS, Sohnle PG, Hasegawa A, Mandel GS: The effect of chemical modification of quartz surfaces on particulateinduced pulmonary inflammation and fibrosis in the mouse. Am Rev Resp Dis 141: 111–116, 1990

    Google Scholar 

  40. Evans PH, Brown RC, Poole A: Modification of the in vitro activities of amosite asbestos by surface derivatization. J Toxicol Environ Health 11: 535–543, 1983

    Google Scholar 

  41. Zalma R, Bonneau L, Guignard J, Pezerat H, Jaurand MC: Formation of oxy radicals by oxygen reduction arising from the surface activity of asbestos. Can J Chem 65: 2338–2341, 1987

    Google Scholar 

  42. Zalma R, Bonneau L, Guignard J, Pezerat H: Production of hydroxyl radicals by iron solid compounds. Toxic Environ Chem 13: 171–187, 1987

    Google Scholar 

  43. Zalma R, Guignard J, Pezerat H: Production of radicals arising from surface activity of fibrous minerals. In: B.T. Mossman, R.O. Bégin (eds). Effects of Mineral Dusts on Cells. NATO ASI Series, Vol. H30. Springer-Verlag, Berlin Heidelberg, 1989, pp 257–264.

    Google Scholar 

  44. Gulumian M, van Wyk JA: Lipid peroxidation by mineral dusts and fibres: ESR studies of oxygen uptake during peroxidation of lipids in multilamellar liposomes. S Afr J Sci 87: 591–593, 1991

    Google Scholar 

  45. Yamano Y, Kagawa J, Hanoka T, Takahashi T, Kasai H, Tsugane S, Watanabe S: Oxidative DNA damage induced by silica in vivo. Environ Res 69: 102–107, 1995

    Google Scholar 

  46. Jackson JH, Schraufstatter IU, Hyslop PA, Vosbeck K, Sauerheber R, Weitzman SA, Cochrane CG: Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J Clin Invest 80: 1090–1095, 1987

    Google Scholar 

  47. Hardy JA, Aust AE: The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16: 319–325, 1995

    Google Scholar 

  48. Kupchan SM, Atland HW: Requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds. J Med Chem 16: 913–917, 1973

    Google Scholar 

  49. Yu XF, Zou CQ, Lim MB: Observation of the effect of tetrandrine on experimental silicosis of rats. Ecotoxicol Environ Saf 7: 306–312, 1983

    Google Scholar 

  50. Li Q, Xu Y, Zhow Z, Chen X, Huang X, Chen S, Zhun C: The therapeutic effect of tetrandrine on silicosis. Chin J Tuberc Resp Diseases 4: 321–328, 1981

    Google Scholar 

  51. Castranova V, Kang J-H, Ma JKH, Mo C-G, Malanga CJ, Moore MD, Schwegler-Berry D, Ma JYC: Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: Correlation between binding affinity, inhibitory potency, and antifibrotic potential. Toxicol Appl Pharmacol 108: 242–252, 1991

    Google Scholar 

  52. Ma JKH, Mo C-G, Malanga CJ, Ma JYC, Castranova V: Binding of bisbenzylisoquinoline alkaloids to phosphatidylcholine vesicles and alveolar macrophages: Relationship between binding affinity and antifibrotic potential of these drugs. Exp Lung Res 17: 1061–1077, 1991

    Google Scholar 

  53. Castranova V, Kang JH, Moore MD, Pailes WH, Frazer DG, Schwegler-Berry D: Inhibition of stimulant-induced activation of phagocytic cells with tetrandrine. J Leuk Biol 50: 412–422, 1991

    Google Scholar 

  54. Liu L, Chen N, Cai G, Li Z, Yang J, Li Y: Studies on the effects of tetrandrine on microtubules. I. Biochemical observation and electron microscopy. Ecotoxicol Environ Safety 15: 142–148, 1988

    Google Scholar 

  55. Chen N, Liu L, Cai G, Yang J, Li Y: Studies on the effects of tetrandrine on microtubules. II. Observations with immunofluorescence techniques. Ecotoxicol Environ Saf 15: 149–152, 1988

    Google Scholar 

  56. Cao ZF: Scavenging effect of tetrandrine on active oxygen radicals. Planta Med 62: 413–414, 1996

    Google Scholar 

  57. Shi X, Mao Y, Saffiotti U, Wang L, Rojanasakul Y, Leonard SS, Vallyathan V: Antioxidant activity of tetrandrine and its inhibition of quartz-induced lipid peroxidation. Toxicol Environ Health 46: 233–248, 1995

    Google Scholar 

  58. Pang L, Hoult RS: Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid accompanied by an overproduction of prostaglandins. Biochem Pharmacol 53: 773–782, 1997

    Google Scholar 

  59. He Y, Liu B, Miao Q, Zhang Q: The effects of tetrandrine on collagen gene expression in SiO2-induced experimental silicosis. The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles. Abstract 106. September 15–18, 1996

  60. Khan SG, Shahid A, Rahman Q: Protective role of ascorbic acid against asbestos induced toxicity in rat lung. Drug Chem Toxicol 13: 249–256, 1990

    Google Scholar 

  61. Mironova GE: Effect of ascorbic acid on development of pneumofibrosis caused by silicon dioxide. Vopr Med Khim 37: 84–86, 1991

    Google Scholar 

  62. Holts G, Bresnick E: Ascorbic acid inhibits the squamous metaplasia that results from treatment of tracheal explants with asbestos or benzo[a]pyrene-coated asbestos. Cancer Lett 42: 23–28, 1988

    Google Scholar 

  63. Braughler JM, Pregenzer JF, Chase RL, Duncan LA, Jacobsen EJ, McCall JM: Novel 21–aminosteroids as potent inhibitors of irondependent lipid peroxidation. J Biol Chem 262: 10438–10440, 1987

    Google Scholar 

  64. Antonini JM, van Dyke K, DiMatteo M, Reasor MJ: Attenuation of acute inflammatory effects of silica in rat lung by 21–aminosteroid, U74389G. Inflammation 19: 9–21, 1995

    Google Scholar 

  65. Maksimenko AV, Grigor'eva EL, Bezrukavnikova LM, Petrov AD, Tishchenko EG, Arkhipova OG, Torchilin VP: Antifibrotic effect of dextran aldehyde-modified superoxide dismutase in experimental silicosis. Byull Eksp Biol Med 112: 265–267, 1991

    Google Scholar 

  66. Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D, Mickey R, Vacek P, Kagan E: Inhibition of lung injury, inflammation and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Resp Dis 141: 1266–1271, 1990

    Google Scholar 

  67. Mossman BT, Surinrut P, Brinton BT, Marsh P, Heintz NH, Lindau-Shepard B, Shaffer JB: Transfection of a manganese-containing superoxide dismutase gene into hamster tracheal epithelial cells ameliorates asbestos-mediated cytotoxicity. Free Rad Biol Med 21: 125–131, 1996

    Google Scholar 

  68. Goss GD, McBurney MW: Physiological and clinical aspects of vitamin A and its metabolites. Crit Rev Clin Lab Sci 29: 185–215, 1992

    Google Scholar 

  69. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE, Watson RR: The effects of 13–cis-retinoic acid and β-carotene on cellular immunity in humans. Cancer (Phila) 67: 1556–1560, 1991

    Google Scholar 

  70. Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, Balmes J, Cherniack MG, Cullen MR, Glass A, Keogh J, Meyskens F Jr, Valanis B, Williams J Jr: The β-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Res (suppl)54: 2038s–2043s, 1994

    Google Scholar 

  71. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Hammar S: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 334: 1150–1155, 1996

    Google Scholar 

  72. Chuwers P, Barnhart S, Blanc P, Brodkin CA, Cullen M, Kelly T, Keogh J, Omenn G, Williams J, Balmes JR: The protective effect of β-carotene and retinol on ventilatory function in an asbestos-exposed cohort. Am J Resp Crit Care Med 155: 1066–1071, 1997

    Google Scholar 

  73. Schiffman MH, Pickle LW, Fontham E, Zahm SH, Falk R, Mele J, Correa P, Fraumeni JF Jr: Case-control study of diet and mesothelioma in Louisiana. Cancer Res 48: 2911–2915, 1988

    Google Scholar 

  74. Rees DJ: A case-control study of mesothelioma in South Africa. A thesis submitted to the Faculty of Medicine, University of Cape Town, for the degree of Doctor of Philosophy. Johannesburg, 1995

  75. Sahu AP: Chronic lung injury due to mineral particles: Possible prevention of their fibrogenic potential. The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles. Abstract 107. September 15–18, 1996

  76. Hoffman H, Hatherill JR, Crowley J, Harada H, Yonemaru M, Zheng H, Ishizaka A, Raffin TA: Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs. Am Rev Resp Dis 143: 289–293, 1991

    Google Scholar 

  77. O'Neil CA, Giri SN, Wang Q, Perricone MA, Hyde DM: Effects of dibutyryl cyclic adenosine monophosphate on bleomycin-induced lung toxicity in hamsters. J Appl Toxicol 12: 97–111, 1992

    Google Scholar 

  78. Kennedy TP, Michael JR, Hoidal JR, Hasty D, Sciuto AM, Hopkins C, Lazar R, Bysani GK, Tolley E, Gurtner GH: Dibutyryl cAMP, aminophylline, and β-adrenergic agonists protect against pulmonary edema caused by phosgene. J Appl Physiol 67: 2542–2552, 1989

    Google Scholar 

  79. Riva CM, Morganroth ML, Ljungman AG, Schoeneich SO, Marks RM, Todd RF III, Ward PA, Boxer LA: Iloprost inhibits neutrophilinduced lung injury and neutrophil adherence to endothelial monolayers. Am J Resp Cell Mol Biol 3: 301–309, 1990

    Google Scholar 

  80. Ochoa L, Waypa G, Mahoney JR Jr, Rodriguez L, Minnear FR: Contrasting effects of hypochlorous acid and hydrogen peroxide on endothelial permeability. Prevention with cAMP drugs. Am J Crit Care Med 156: 1247–1255, 1997

    Google Scholar 

  81. Israbian VA, Weitzman SA, Kamp DW: Dibutyryl cAMP attenuates asbestos-induced pulmonary epithelial cell cytotoxicity and decline in ATP levels. Am J Physiol 267: L518–L525, 1994

    Google Scholar 

  82. Morosova KI, Aronova GV, Katsnelson BA, Velichkovski BT, Genkin AM, Einichnykh LN, Privalova LI: On the defensive action of glutamate against the cytotoxicity and fibrogenicity of quartz dust. Br J Indust Med 39: 244–252, 1982

    Google Scholar 

  83. Morosova KI, Katsnelson BA, Rotenberg YS, Belobragina GV: A further experimental study of the antisilicotic effect of glutamate. Br J Indust Med 41: 518–525, 1984

    Google Scholar 

  84. Flowers ES: Metal-Micelle asbestos and treatment of asbestos and other mineral silicates to reduce their harmful properties: US Patent 4,328,197; May 4; assigned to Flow General Inc. McLean, Va., 1982

  85. Gulumian M, van Wyk JA, Kolk B: Detoxified crocidolite exhibits reduced radical generation which could explain its lower toxicity: ESR and Mössbauer studies. In: BT Mossman, RO Bégin (eds). Effects of Mineral Dusts on Cells. NATO ASI Series, Vol. H30. Springer-Verlag, Berlin, Heidelberg, 1989, pp 197–204

    Google Scholar 

  86. Gulumian M, van Wyk JA, Hearne GR, Kolk B, Pollak H: ESR and Mössbauer studies on detoxified crocidolite: Mechanism of reduced toxicity. J Inorg Biochem 50: 133–143, 1993

    Google Scholar 

  87. Hahon N, Vallyathan V, Booth JA, Sepulveda MJ: In vitro biologic response to native and surface-modified asbestos. Environ Res 39: 345–355, 1986

    Google Scholar 

  88. Gulumian, M, Nkosibomvu ZL, Channa K, Pollak H: Can microwave radiation at high temperatures reduce the toxicity of fibrous crocidolite asbestos? Environ Health Perspect 105(suppl 5): 1041–1044, 1997

    Google Scholar 

  89. Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA: Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: Role of iron-catalyzed free radicals. Am J Physiol 268: L471–L480, 1995

    Google Scholar 

  90. Kamp DW, Israbian VA, Yeidandi AV, Panos RJ, Graceffa P, Weitzman SA: Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos. Toxicol Pathol 23: 689–695, 1995

    Google Scholar 

  91. Weitzman SA, Weitberg AB: Asbestos-catalysed lipid peroxidation and its inhibition by desferroxamine. Biochem J 225: 259–262, 1985

    Google Scholar 

  92. Weitzman SA, Chester JF, Graceffa P: Binding of deferoxamine to asbestos fibers in vitro and in vivo. Carcinogenesis 9: 1643–1645, 1988

    Google Scholar 

  93. Chao C-C, Aust AE: Effect of long-term removal of iron from asbestos by desferrioxamine B on subsequent mobilization by other chelators and induction of DNA single-strand breaks. Archiv Biochem Biophys 308: 64–69, 1994

    Google Scholar 

  94. Driscoll KE, Maurer JK: Cytokine and growth factor release by alveolar macrophages: Potential biomarkers of pulmonary toxicity. Toxicol Pathol 19: 398–405, 1991

    Google Scholar 

  95. Williams AO, Saffiotti U: Growth factors and gene expression in silica-induced fibrogenesis and carcinogenesis. Appl Occup Environ Hyg 10: 1089–1098, 1995

    Google Scholar 

  96. Piguet PF, Vesin C, Grau GE, Thompson RC: Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5: 57–61, 1993

    Google Scholar 

  97. Henderson RF, Harkema JR, Hotchkiss JA, Boehme DS: Effect of blood leukocyte depletion on the inflammatory response of the lung to quartz. Toxicol Appl Pharmacol 109: 127–136, 1991

    Google Scholar 

  98. DiMatteo M, Reasor MJ: Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol Appl Pharmacol 142: 411–421, 1997

    Google Scholar 

  99. Liu K, Situ R, Liao J: The effect of anti basic fibroblast growth factor on the development of experimental silicosis bacillus. Chung Hua Chieh Ho Ho Hsi Tsa Chih (CYH) 18: 351–353, 1995

    Google Scholar 

  100. Piguet PF, Rosen H, Vesin C, Grau GE: Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Resp Dis 147: 435–441, 1993

    Google Scholar 

  101. Rosmanith J, Breining H: The reduction of quartz effect by natural anhydrite in animal experiment. Wiss Umwelt 182–188, 1988

  102. Plastinina IuV, Privalova LI, Tereshin Slu, Katsnel'son BA, Kislitsina NS: Precutaneous effects of iodine inhibit the development of experimental silicosis. Med Tr Prom Ekol 7: 16–20, 1996

    Google Scholar 

  103. Li H, Wu Z, Zeng X, Liu S, Zheng Z, Zeng L, Duanmu B, Ke F, Yang H, Qing Y: Pathological observation of experimental asbestosis treated by hydroxypiperquin phosphate in dogs. Huaxi Yike Daxue Xuebao 22: 181–184, 1991

    Google Scholar 

  104. Soodaeva SK, Ostrakhovich EA, Velichkovskii BT: Changes in the blood serum antioxidant system and peroxidation of lipids during exposure to asbestos. Byull Eksp Biol Med 118: 145–147, 1994

    Google Scholar 

  105. Yu L, Zhou CQ, Li YR, Qu L, Xing KJ, Du QC: A biochemical study on combined treatment of experimental silicosis with tetrandrine-PVNO and tetrandrine-QOHP in rats. Biomed Environ Sci 8: 265–268, 1995

    Google Scholar 

  106. Muhle H, Bellmann B, Pott F: Durability of various mineral fibres in rat lungs. In: R.C. Brown, J.A. Hoskins, N.F. Johnson (eds). Mechanisms in Fibre Carcinogenesis. NATO ASI Series A. Life Sciences 223, Plenum Press, New York, 1991, pp 181–187

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gulumian, M. The role of oxidative stress in diseases caused by mineral dusts and fibres: Current status and future of prophylaxis and treatment. Mol Cell Biochem 196, 69–77 (1999). https://doi.org/10.1023/A:1006918212866

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006918212866

Navigation